NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.040
+0.040 (4.00%)
At close: Feb 13, 2026, 4:00 PM EST
0.9806
-0.0590 (-5.71%)
After-hours: Feb 13, 2026, 7:27 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $34.73 million as of February 13, 2026. Its market cap has increased by 41.06% in one year.
Market Cap
34.73M
Enterprise Value
34.07M
1-Year Change
41.06%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $34.73M, a decrease of -46.24%. That is a compound annual growth rate of -13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 34.73M | 52.08% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 36.76M |
| Celularity | 36.48M |
| Atossa Therapeutics | 36.17M |
| Outlook Therapeutics | 36.02M |
| Pluri | 35.52M |
| Tvardi Therapeutics | 34.90M |
| Hyperion DeFi | 34.77M |
| Actinium Pharmaceuticals | 34.63M |